Previously, immunological treatment with CP was reported during the Spanish flu pandemic in 1918 for CMV or parvovirus B19 infections, measles, mumps, varicella, coronavirus-induced Severe Acute Respiratory Syndrome (SARS), and Middle East Respiratory Syndrome (MERS) [14,15,16]. Here, CP is linked to severe acute respiratory syndrome.